VCAM-1 targeted alpha-particle therapy for early brain metastases

BACKGROUND: Brain metastases (BM) develop frequently in patients with breast cancer. Despite the use of external beam radiotherapy (EBRT), the average overall survival is short (6 months from diagnosis). The therapeutic challenge is to deliver molecularly targeted therapy at an early stage when rela...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Corroyer-Dulmont, Aurélien, Valable, Samuel, Falzone, Nadia, Frelin-Labalme, Anne-Marie, Tietz, Ole, Toutain, Jérôme, Soto, Manuel Sarmiento, Divoux, Didier, Chazalviel, Laurent, Pérès, Elodie A, Sibson, Nicola R, Vallis, Katherine A, Bernaudin, Myriam
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Basic and Translational Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7162423/
https://ncbi.nlm.nih.gov/pubmed/31538194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz169
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki